A Synthetic Nanoparticle Based Vaccine Approach Targeting MSP4/5 Is Immunogenic and Induces Moderate Protection Against Murine Blood-Stage Malaria

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.00331
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA


Related search